We quantified increased serum levels of IL-5 and IL-10 among patients with EGPA (Supplemental Figure 1, A and B; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.143366DS1), particularly during active disease. This evidence concerns the gene IL10 and eosinophilic granulomatosis with polyangiitis.